A Q-TWiST analysis of adjuvant chemotherapy in non-small cell lung cancer (NSCLC) in the NCIC CTG JBR.10 trial

被引：0
|
作者：
Jang, R. W.
Le Maitre, A.
Ding, K.
Winton, T. L.
Bezjak, A.
Seymour, L.
Shepherd, F. A.
Leighl, N. B.
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Natl Canc Inst Canada, Kingston, ON, Canada
[3] Univ Alberta, Edmonton, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.6535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6535
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Adjuvant chemotherapy of non-small cell lung cancer
    Crinò, L
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 215 - 216
  • [32] Adjuvant chemotherapy in non-small cell lung cancer
    Taillade, L
    Soria, JC
    André, F
    Grunenwald, D
    Dunant, A
    Pignon, JP
    Le Chevalier, T
    BULLETIN DU CANCER, 2004, 91 (01) : 63 - 67
  • [33] Bene fi t of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial
    Toubat, Omar
    Ding, Li
    Ding, Keyue
    Wightman, Sean C.
    Atay, Scott M.
    Harano, Takashi
    Kim, Anthony W.
    David, Elizabeth A.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2024, 36 (02) : 261 - 270
  • [34] Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10
    Grieve, Stacy
    Ding, Keyue
    Moore, Jonathan
    Finniss, Mathew
    Ray, Ayush
    Lees, Miranda
    Hossain, Faisal
    Murugesan, Alli
    Agar, Jane
    Acar, Cenk
    Taylor, James
    Shepherd, Frances A.
    Reiman, Tony
    ESMO OPEN, 2020, 5 (02)
  • [35] Impact of hemoglobin (Hb) on outcomes of adjuvant chemotherapy (ACT) with cisplatin/vinorelbine in patients (pts) with completely resected non-small cell lung cancer (NSCLC) in JBR.10.
    Gauthier, I
    Ding, K
    Winton, T
    Shepherd, F
    Livingston, R
    Johnson, DH
    Rigas, JR
    Whitehead, M
    Graham, B
    Seymour, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 670S - 670S
  • [36] Role of adjuvant chemotherapy in Non Small Cell Lung Cancer (NSCLC)
    Le Chevalier, T
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 171 - 177
  • [37] Compliance of adjuvant chemotherapy in non-small cell lung cancer (NSCLC); No longer an issue.
    Aljubran, A.
    Leighl, N.
    Pintilie, M.
    Feld, R.
    Burkes, R.
    Shepherd, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 402S - 402S
  • [38] CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    KLASTERSKY, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (07): : 1035 - 1038
  • [39] Adjuvant chemotherapy for resected non-small cell lung cancer (NSCLC): the West of Scotland Experience
    Slater, S.
    Nowicki, S.
    Brown, J.
    Steele, N.
    LUNG CANCER, 2012, 75 : S11 - S11
  • [40] Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
    Liang, Ying
    Wakelee, Heather A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 403 - 410
12345